ChuanLiang Cui
5PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 06, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights.Xuan Wang, Hui Tian, Zhihong Chi
|Oct 04, 2024
Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial.Bixia Tang, Yu Chen, Yu Jiang
|Jan 10, 2024
SAFFRON-103: a phase Ib study of sitravatinib plus tislelizumab in anti-PD-(L)1 refractory/resistant advanced melanoma.Xuan Wang, Hongming Pan, Jiuwei Cui
|Jan 02, 2023
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy.Jie Dai, Xue Bai, Xuan Gao
|Feb 21, 2021
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China.Yang Wang, Bin Lian, Lu Si
Pageof 1
